Rezera sets an $11 to $13 price range for its $200 million Nasdaq IPO
As seen on the 24/7 Wall St. homepage on November 9, 2026.
Rezera sets $11-$13 range for $200 million Nasdaq IPO
Rezera's second amendment puts real terms on the table: 16.67 million shares at $11 to $13, a roughly $200 million Nasdaq raise with Jefferies, TD Cowen, Cantor and Wedbush PacGrow running the book. Pricing is the next step, so anyone wanting allocation has a narrow window left.
Continue ReadingShow less
Rezera's second amended filing moves the deal from placeholder territory into something concrete, with shares offered at $11 to $13 apiece on Nasdaq. A second amendment signals that the company and its bankers have stress-tested demand and are ready to price.
Jefferies, TD Cowen, Cantor, and Wedbush PacGrow are running the book, a four-bank syndicate that spreads distribution across institutional and growth-focused investor channels. The presence of multiple lead underwriters typically reflects an effort to widen the net of potential buyers before final allocation.
Sponsored
With terms now set, pricing is the immediate next milestone. The window between a priced range and the actual pricing date is often short, leaving prospective buyers little time to build a position in the aftermarket at or near the offer price.
The $11 to $13 range gives investors a valuation anchor to work with as they weigh the deal. Where the final price lands within, at, or outside that range will be an early read on how strong institutional demand proved to be during the roadshow.
Mentioned: RZRA